Clinical Trial Technology Editorial
-
AI Technologies Drive Drug Development And Enhance Patient Experience In Neurology & Rare Diseases
3/21/2024
Digital healthcare and AI technologies play a crucial role in exploring and treating a range of rare diseases as we welcome a new era of personalized care and potentially better patient outcomes.
-
3 Tips For Selecting Your eTMF Platform
3/7/2024
Each eTMF platform presents its own set of advantages and drawbacks. Be sure to incorporate these three tips when considering a new eTMF vendor and its services.
-
Leveraging AI For Data Analysis In Pharmacy-Based Trials
2/28/2024
Leveraging AI for data analysis in pharmacy-based trials holds immense potential for revolutionizing drug development and healthcare delivery.
-
AI's Role In Advancing Rare Disease Research
2/27/2024
IndoUSrare experts explore the global issues in rare disease research and examine how AI is poised to revolutionize the diagnosis and treatment of these often-overlooked conditions.
-
3 Areas Where AI Could Revolutionize Patient Recruitment And Retention
2/6/2024
Explore three ways in which AI can make a positive impact on patient recruitment and retention, as identified by life sciences consultant Ross Jackson.
-
It’s Hard To Predict AI’s Real Value To Clinical Trials
2/1/2024
Sunny Kumar, a partner at GSR Ventures, plans to talk about AI and ML use in clinical trials during the SCOPE Summit panel, “The Future of Clinical Trial Tech: Perspectives from Different Investors.”
-
4 Things I’m Looking Forward To At SCOPE 2024
2/1/2024
The Summit for Clinical Ops Executives (SCOPE) begins Feb. 11. Discover four things Executive Editor Abby Proch is looking forward to at the annual event.
-
The Impact Of Protocol Design On An IRT System
1/31/2024
DTP and home treatment studies can get expensive — and be a hassle to patients — if the IRT element isn’t well planned for during trial design. In their SCOPE Summit presentation, Irina Grishina and Kelsey Kern of CSL Behring plan to share their personal anecdotes and lessons learned from both types of trials as they pertain to IRT.
-
What Is Clinical Trial Tokenization?
1/30/2024
Tokenization in clinical trials is still a new concept to many sponsors — and their patients who are volunteering for the studies. At his SCOPE Summit presentation, Tom Dougherty of Pfizer will explain this concept and discuss what trials are a fit.
-
Digitizing The Clinical Protocol: Small Steps For Seismic Change
1/30/2024
A proliferation of clinical trial platform systems has meant increased friction for data exchange. Discover how TransCelerate is tackling this problem with small steps that yield big results.